Description

5-((4-[5-(4-Fluorophenyl)-1,3,4-Oxadiazol-2-Yl]Piperidin-1-Yl)Methyl)-2-(Trifluoromethyl)Pyridine is a high-value, complex heterocyclic compound designed for advanced research and development. This molecule is of significant interest in pharmaceutical chemistry due to its unique structural features, which combine a piperidine core with fluorinated aromatic and oxadiazole moieties. It serves as a critical pharmaceutical intermediate or reference standard for medicinal chemists and R&D teams in the life sciences sector, particularly those developing novel therapeutic agents.

Application

This specialized chemical is engineered for high-end research applications where precise molecular architecture is paramount. Its primary uses include:

• Pharmaceutical Intermediate: A key building block in the synthesis of novel drug candidates, particularly in central nervous system (CNS) and oncology research.
• Medicinal Chemistry Research: Used for structure-activity relationship (SAR) studies to optimize biological activity and pharmacokinetic properties.
• Reference Standard: Serves as an analytical standard for quality control and method development in API (Active Pharmaceutical Ingredient) manufacturing.
• Biochemical Tool Compound: Utilized in vitro and in vivo to probe specific biological targets and pathways.
• Custom Synthesis: A starting material for the contract synthesis of more complex, proprietary molecules for clinical trials.

Basic Information

Product Name	5-((4-[5-(4-Fluorophenyl)-1,3,4-Oxadiazol-2-Yl]Piperidin-1-Yl)Methyl)-2-(Trifluoromethyl)Pyridine
CAS No.	909666-64-4
Molecular Formula	C20H16F4N4O
Molecular Weight	412.37 g/mol
Synonyms	5-((4-(5-(4-Fluorophenyl)-1,3,4-oxadiazol-2-yl)piperidin-1-yl)methyl)-2-(trifluoromethyl)pyridine; 2-(Trifluoromethyl)-5-[[4-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]-1-piperidinyl]methyl]pyridine; 909666-64-4; UNII-8R8T6Q8W4T; 8R8T6Q8W4T; CHEMBL3186662; BDBM50389379; AKOS015915889
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to stringent quality protocols. Every batch is characterized and purified to meet the exacting standards required for pharmaceutical R&D. Certificates of Analysis (COA) are provided, detailing purity, identity, and impurity profiles as determined by advanced analytical techniques including HPLC, NMR, and mass spectrometry. We ensure traceability and consistency to support your critical research and development workflows.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). For long-term storage, consider storing under an inert atmosphere to maintain stability. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Individual impurity ≤ 1.0%
Total Impurities	≤ 3.0%
Residual Solvents (GC)	Complies with ICH guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.